Objectives: This study examines the length of time between when a patent application is filed in Canada for a new drug and when it is available for patients (time to market) and various components of
This statistic shows the number of inspections the Food and Drug Administration (FDA) made of domestic and foreign medical device establishments in the U.S. from FY 2009 to FY 2024. In FY 2024, the FD
I use variation in approval time for generic drugs to shed light on the objectives of the federal agency in charge of granting entry permission for these drugs (FDA). Applications belonging to firms l
